Actinium Pharmaceuticals, Inc. - 10-Q Filing
Actinium Pharmaceuticals reported a net loss of $5,522 thousand ($0.18 per share) for Q1 2026 compared to a net loss of $15,938 thousand ($0.51 per share) in the same period last year. The company's cash and equivalents decreased from $47,998 thousand at December 31, 2025, to $42,132 thousand as of March 31, 2026.
Tickers: $ATNM